Inventor · disambiguated record
Christopher Gaëtan Housseman
Also filed as: HOUSSEMAN CHRISTOPHER GAÉTAN
12 granted patents·4 pending applications·46 citations·filing 2014–2022
87Inventor score
Top patents by PatentIndex Score
16 records- 0196US9981910B2Substituted pyrrolidines and methods of useABBVIE SARL·Filed 2017·Granted May 29, 2018·31 cites·23 claims
- 0286US10259810B2N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of useABBVIE SARL·Filed 2017·Granted Apr 16, 2019·5 cites·8 claims
- 0384US9890158B2N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of useABBVIE SARL·Filed 2016·Granted Feb 13, 2018·5 cites·50 claims
- 0479US10988454B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2018·Granted Apr 27, 2021·1 cites·1 claims
- 0576US10647717B2N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of useABBVIE SARL·Filed 2019·Granted May 12, 2020·1 cites·3 claims
- 0673US9796711B2Substituted pyrazolo[3,4-b]pyridin-6-carboxylic acids and method of useABBVIE S ÀR L·Filed 2016·Granted Oct 24, 2017·2 cites·42 claims
- 0772US2021238159A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE OVERSEAS SARL·Filed 2021·Application pending·0 cites
- 0871US10844042B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 24, 2020·0 cites·2 claims
- 0971US10844041B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 24, 2020·0 cites·2 claims
- 1071US10829473B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 10, 2020·0 cites·2 claims
- 1170US9796719B2Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2014·Granted Oct 24, 2017·1 cites·15 claims
- 1269US10981890B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Apr 20, 2021·0 cites·1 claims
- 1359US2019202823A1N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USEABBVIE SARL·Filed 2019·Application pending·0 cites
- 1451US2024246992A1Macrocyclic lrrk2 kinase inhibitorsSERVIER LAB·Filed 2022·Application pending·0 cites
- 1548US2018127425A1Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2017·Application pending·0 cites
- 1635US10130622B2Compounds for treatment of cystic fibrosisABBVIE SARL·Filed 2016·Granted Nov 20, 2018·0 cites·33 claims
Join the waitlist — get patent alerts
Get an alert when Christopher Gaëtan Housseman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →